Last edition
News about "Haffkine Biopharma news "
Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum
Haffkine Biopharma, a Maharashtra state PSU proposed to produce 22.8 crore Covaxin doses per annum under technology transfer arrangement with Bharat Biotech. The production will take place at the Parel complex of the company in Mumbai
Haffkine Biopharma News | 02/06/2021 | By Darshana | 257
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members